Madrigal Pharmaceuticals, Inc.
MDGL • NASDAQ • Stock Fundamentals
Madrigal Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William J. Sibold, with a market cap of $10.9B.
Market Cap$10.9B
Employees376.0
CEOWilliam J. Sibold
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Madrigal Pharmaceuticals, Inc. FAQ
Common questions about Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. (MDGL) has a market capitalization of $10.9B and trades on NASDAQ.
Madrigal Pharmaceuticals, Inc. has approximately 376 employees.